News

Allurion outlines path to FDA submission and expects revenue ramp as B2B2C strategy expands in 2025
Q1 2025 Management View Shantanu Gaur, CEO, stated the company "delivered the first quarter in line with expectations, ...
Allurion Technologies Inc. (ALUR) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ETCompany ParticipantsTara Brady - Interim CFOShantanu Gaur ...